This Could End Very Badly
Submitted by QTR's Fringe Finance
If you missed what’s new, this past week I highlighted one name that I’m watching as a potential target for a big pharma buyout. It’s a risky, binary outcome, but one that has piqued my attention nonetheless. I shared it with subscribers:
Watching A Potential Big Pharma Buyout
This week I also wrote about why SpaceX’s forthcoming IPO could be a $2 trillion trapdoor that I would personally avoid:
SpaceX's IPO Feels Like A $2 Trillion Trap Door
🔥 80% Off This Weekend
At any time this weekend you can get 80% off an annual subscription to the blog. The discount lasts forever: Get 80% off forever
I also wrote about one alarming market data point that continues to tell the story to me that this broad market rally to all-time highs may not be so broad…or sustainable…as people would like it to be:
"As Thin As This Playing Card..."
I also recently predicted the next sector of the economy I think could collapse:
The Next Sector To Collapse?
Finally, as of last week, three microcaps I pointed out that I’m watching last month are up an estimated 17.8%, 30.4% and 6.4% respectively already.
I also pointed out one more microcap name worth watching on April 7, which is still mostly unchanged since then but could have longer term potential.
Here’s what else is new on the blog:
Taxing, Borrowing, and Printing: Three Ways America Pays for Government
Bernanke’s Broken Promise: Is It Time To Shrink the Fed Yet?
Phone Service for 94,000 Dead People, and Other Things Congress Won’t Cut
QTR’s Disclaimer: Please read my full legal disclaimer on my About page here. This post represents my opinions only. In addition, please understand I am an idiot and often get things wrong and lose money. I may own or transact in any names mentioned in this piece at any time without warning. Contributor posts and aggregated posts have been hand selected by me, have not been fact checked and are the opinions of their authors. They are either submitted to QTR by their author, reprinted under a Creative Commons license with my best effort to uphold what the license asks, or with the permission of the author.
This is not a recommendation to buy or sell any stocks or securities, just my opinions. I often lose money on positions I trade/invest in. I may add any name mentioned in this article and sell any name mentioned in this piece at any time, without further warning. None of this is a solicitation to buy or sell securities. I may or may not own names I write about and are watching. Sometimes I’m bullish without owning things, sometimes I’m bearish and do own things. Just assume my positions could be exactly the opposite of what you think they are just in case. If I’m long I could quickly be short and vice versa. I won’t update my positions. All positions can change immediately as soon as I publish this, with or without notice and at any point I can be long, short or neutral on any position. You are on your own. Do not make decisions based on my blog. I exist on the fringe. If you see numbers and calculations of any sort, assume they are wrong and double check them. I failed Algebra in 8th grade and topped off my high school math accolades by getting a D- in remedial Calculus my senior year, before becoming an English major in college so I could bullshit my way through things easier.
The publisher does not guarantee the accuracy or completeness of the information provided in this page. These are not the opinions of any of my employers, partners, or associates. I did my best to be honest about my disclosures but can’t guarantee I am right; I write these posts after a couple beers sometimes. I edit after my posts are published because I’m impatient and lazy, so if you see a typo, check back in a half hour. Also, I just straight up get shit wrong a lot. I mention it twice because it’s that important.





